Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2003
06/19/2003US20030114377 Domain binds component from a foreign body selected from gramnegative bacteria and grampositive bacteria, lipopolysaccharide transmitting cellular signals
06/19/2003US20030114376 Tissue-factor-pathway inhibitors for treating eye vision defects
06/19/2003US20030114375 Method for treating cystic fibrosis
06/19/2003US20030114374 Production of vascular endothelial cell growth factor and DNA encoding same
06/19/2003US20030114373 Polypeptides for treating neuro- and musculo-degenerative conditions, drug screening for identifying agonists and antagonists
06/19/2003US20030114372 Isolated DNA encoding amino acid sequences, serine protease inhibitor, host cell transformed with a DNA molecule, Kunitz type Inhibitor, blood coagulation factors
06/19/2003US20030114370 Nucleic acid molecules encoding endostatin protein and peptide fragments thereof
06/19/2003US20030114369 HIV-specific CTL inducing peptides and medicaments for preventing or treating AIDS comprising the peptides
06/19/2003US20030114368 Immunotoxins directed against malignant cells
06/19/2003US20030114367 Composition for the prevention and/or treatment of artherosclerosis
06/19/2003US20030114366 Uniform size, internal reservoirs that contain releaseable cytotoxic agents and communicate through pores filled or covered with release-delaying material and a layer of ligand molecules grafted to the face
06/19/2003US20030114365 Neurotrophic pipecolic acid derivative compounds having an affinity for FKBP-type immunophilins; treating neurodegenrative disorders
06/19/2003US20030114364 Administering lactoferrin and glycomacropeptide; microbiocides
06/19/2003US20030114362 Radical of an amino carboxylic acid bearing a five- membered ring in the peptide backbone; antitumour agents
06/19/2003US20030114361 Antithrombotic compound
06/19/2003US20030114359 Inhibiting and/or reversing the dysfunctional response of vascular endothelial cells to an inflammatory stimulus with thrombin-activatable fibrinolysis inhibitor (tafi) and activated protein c
06/19/2003US20030114357 Antidiabetic agents
06/19/2003US20030114355 Arthroscopic irrigation solution and method for inhibition of pain and inflammation
06/19/2003US20030113914 Antisense modulation of CD81 expression
06/19/2003US20030113912 Hematopoietic stem cell proliferating agents
06/19/2003US20030113897 Genetic engineering; anticancer agents
06/19/2003US20030113894 Therapy for kidney diseases; cardiovascular disorders
06/19/2003US20030113892 Isolated polypeptides and compositions from the venom of P. transvaalicus and methods of use
06/19/2003US20030113891 Method and reagent for the inhibition of NOGO and NOGO receptor genes
06/19/2003US20030113890 Nematode-extracted serine protease inhibitors and anticoagulant proteins
06/19/2003US20030113888 Human ion channels
06/19/2003US20030113881 D-enzyme compositions and methods of their use
06/19/2003US20030113873 Screening modulators of G-protein coupled binding proteins; analgesics; muscle-relaxants; cognition activators; learning enhancement
06/19/2003US20030113871 Glycoprotein hormones; human chorionic gonadotropin; carboxy terminal peptides (ctp); increaseing half life of polypeptides; antipernicious anemia drugs
06/19/2003US20030113870 Polypeptides homologous to VEGF and BMP1
06/19/2003US20030113869 Human FGF gene and gene expression products
06/19/2003US20030113867 Muscle receptor proteins; transport proteins; antitumor agents; antiinflammatory agents; antidiabetic agents; modulation of muscle contraction
06/19/2003US20030113847 Novel nucleic acids and polypeptides
06/19/2003US20030113846 Lipases; lipooxygenases; phospholipases; neuroprotectants; antiinflammatory agents; bradycardial agents; antitumor agents
06/19/2003US20030113844 Delayed rectifier potassium channel subunit
06/19/2003US20030113841 8105, a novel human sugar transporter family member and uses thereof
06/19/2003US20030113840 25 human secreted proteins
06/19/2003US20030113838 Epidermal growth factor; antitumor agents; antiproliferative agents; antiinflammatory agents; mitogen-activated protein kinases
06/19/2003US20030113830 Evaluating haptoglobins antioxidant activity induced by hemoglobin; antidiabetic agents; for sustained release through stents
06/19/2003US20030113820 Monoclonal anti-idiotypic antibody; antitumor agents; anticarcinogenic agents; antiproliferative agents; immunotherapy; hormone antagonist therapy
06/19/2003US20030113818 Monoclonal anti-idiotypic antibody; antitumor agents; anticarcinogenic agents; antiproliferative agents; immunotherapy; hormone antagonist therapy
06/19/2003US20030113812 Evaluating modulators of neuron propagation; bone morphogenetic proteins; epidermal growth factors; erythropoietins; pleiotrophins; hepatocyte growth factors; somatomedins; nerve growth factors; interleukins
06/19/2003US20030113803 Orphan receptor
06/19/2003US20030113799 Variants of corticotropin releasing hormone receptor type 1 and uses thereof
06/19/2003US20030113796 Detecting modulators of cytokine activity; antiinflammatory agents; autoimmune diseases
06/19/2003US20030113795 Membrane protein; cytokines; antitumor agents; anticarcinogenic agents; antiinflammatory agents; cancer diagnosis
06/19/2003US20030113793 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113791 CIF130 inhibits cell cycle progression
06/19/2003US20030113789 Protease peptides; anticarcinogenic agents; neurotransmitters; antidiabetic agents
06/19/2003US20030113787 Caspase recruitment domain (CARD); tumor suppressor genes; oncogenes; antiproliferative agents; antitumor agents; antiinflammatory agents; antiapoptosis
06/19/2003US20030113777 Methods and compositions for the treatment and diagnosis of cellular proliferative disorders using 32222
06/19/2003US20030113775 7118, a human arginine N-methyltransferase family member and uses therefor
06/19/2003US20030113774 P40 protein acts as an oncogene
06/19/2003US20030113772 DNA encoding human alpha 1 adrenergic receptors and uses thereof
06/19/2003US20030113771 DNA encoding human alpha 1 adrenergic receptors and uses thereof
06/19/2003US20030113764 Compositions and methods for the treatment of tumors
06/19/2003US20030113763 Oligonucleotide compositions and their use to induce apoptosis
06/19/2003US20030113752 Detecting demyelinating nervous system disorder by measurement of stem cell factor (SCF)-apoptosis-response gene protein(SARG-1-) protein; antiproliferative agents; microtubule associated protein 1(map1a); cancer screening
06/19/2003US20030113744 Prevention/inhibition of organ damage due to hypoxia, stroke, heart attack, kidney disease and organ transplantation; antiischemic agents; drug screening
06/19/2003US20030113742 Methods and compositions for the modulation of biofilm formation
06/19/2003US20030113733 Transcription factors; nuclear localization peptides; human chorionic gonadotropic hormone(hCG); NF-kappaB/Rel proteins
06/19/2003US20030113719 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113718 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113717 Directed evolution of novel binding proteins
06/19/2003US20030113710 Immobilization; antibiotic resistance; drug screening
06/19/2003US20030113707 Erythrocyte transport protein suspension obtained by removing fibrin and separating erythrocytes from hematocrit; storage stability; antihypoxic agents
06/19/2003US20030113355 Nontoxic vernix compositions and method of producing
06/19/2003US20030113349 Reducing dermal and subdermal glandular secretions
06/19/2003US20030113348 Non-laboratory strain used in the manufacture of a medicament for the oncolytic treatment of cancer; anticancer agents
06/19/2003US20030113343 Identification and characterization of novel pneumococcal choline binding protein, CbpG, and diagnostic and therapeutic uses thereof
06/19/2003US20030113341 Methods of using FLT3-ligand in the treatment of cancer
06/19/2003US20030113340 Methods of promoting tolerogenic immune responses and compositions therefor
06/19/2003US20030113338 Immunogenic detoxified mutant e. coli lt-a toxin
06/19/2003US20030113337 High efficiency tissue specific compound delivery system using streptavidin-protein a fusion protein
06/19/2003US20030113334 Cytotoxic antibodies specifically bind to proteins which were expressed in lymphatic tumors
06/19/2003US20030113333 A kit containing a binding protein and a carrier molecule, binds with a hapten moiety and binds with a target antigen; monoclonal antibodies and engineered antibodies
06/19/2003US20030113331 An antagonist specifically binds to a denatured collagens; antitumor agents, antimetastasis agents; monoclonal antibodies; drug screening for denatured collagen antagonists
06/19/2003US20030113328 Regulation of T cell responses, T cell proliferation, and induction of T cell death
06/19/2003US20030113326 Oligodendrocyte-myelin glycoprotein (OMgp)-specific binding agents, receptor binding assays; promoting nerve fiber growth
06/19/2003US20030113325 Oligodendrocyte-myelin glycoprotein (OMgp)-specific binding agents, receptor binding assays; promoting nerve fiber growth
06/19/2003US20030113324 Neuropilin/VEGF-C/VEGFR-3 materials and methods
06/19/2003US20030113323 High mobility group proteins; diagnostic monitoring the severity or potential lethality of sepsis or septic shock, measuring the serum protein concentration of patient, treating weight loss or obesity
06/19/2003US20030113321 Novel G-protein-coupled receptor protein and its DNA
06/19/2003US20030113319 Method and pharmaceutical composition for inhibiting premature rapture of fetal membranes, ripening of uterine cervix and preterm labor in mammals
06/19/2003US20030113318 TNF inhibition for the treatment of pre-menstrual syndrome and primary dysmenorrhea
06/19/2003US20030113317 A T cell death-associated protein, its encoding cDNA and antibody that specifically binds the protein; Useful in diagnosis, prognosis and evaluation of progression or treatment of cancer
06/19/2003US20030113312 Skin barrier function and cohesion through enhanced stratum corneum acidification
06/19/2003US20030113311 Pertussis toxin and analogs exhibit an adenosine-5* diphosphate-ribosyltransferase activity, useful in promoting prophylactic and/or therapeutic responses against another target antigen in a mammal patient
06/19/2003US20030113310 Enteral administration to a mammal a preparation containing a glucose isomerase enzyme capable of converting ingested carbohydrate or digestion product into more absorbable component while reducing the actual metabolic calories
06/19/2003US20030113309 Administering to a patient a compound for increasing neuronal metabolism of histamine to a histamine H2 agonist, to stimulate production of adenosine 3*,5*- cyclic phosphate at a level which maintains myelin against self degeneration
06/19/2003US20030113305 Compositions and methods for treating diabetes
06/19/2003US20030113303 Delivering a translocation stimulator to a target zone of the tissue, introducing human embryonic stem cells to the mammal for homing the human to the target zone of the tissue for effecting myogenesis at the target zone
06/19/2003US20030113298 Applying the lytic protein, peptides, or peptide fragments to the mucosal surface, produced by infecting a bacterium causing infection with a bacteriophage specific for the bacteria
06/19/2003US20030113296 A tissue-specific transcriptional regulatory sequence(promoter or enhancer) operably linked to the coding region of a gene that is essential of replication of the vector (DNA tumor viral vector)
06/19/2003US20030113292 Interferon-gamma-inducing factor (IGIF/IL-18); promoting differentiation of CD4-lymphocytes
06/19/2003US20030113279 Photoactivatable composition and uses thereof
06/19/2003US20030113278 Treatment of excessive radiation (e.g. sunburn) exposure
06/19/2003US20030113273 Aerosolized dry powders for high speed absorption
06/19/2003US20030113271 Comprises plasminogen activator and surfactant to promote fibrinolysis and/or reduce inflammation; aerosols
06/19/2003US20030113270 Vasoactive intestinal peptides for glaucomatous retinopathy
1 ... 1825 1826 1827 1828 1829 1830 1831 1832 1833 1834 1835 1836 1837 1838 1839 1840 1841 1842 1843 1844 1845 ... 3163